Various effects of AAV9-mediated βARKct gene therapy on the heart in dystrophin-deficient (mdx) mice and δ-sarcoglycan-deficient (Sgcd-/-) mice

Authors:

Abstract
No abstract available
Funding Information
  • Bundesministerium für Forschung, Technologie und Raumfahrt
  • National Institutes of Health (P01 HL075443, P01 HL108806, R37 HL061690)
  • Deutsches Zentrum für Herz-Kreislaufforschung

This publication has 43 references indexed in Scilit: